Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.6K Buy
273
+130
+91% +$12.2K ﹤0.01% 379
2026
Q1
$16.9K Buy
143
+1
+0.7% +$124 ﹤0.01% 396
2025
Q4
$17.9K Buy
142
+2
+1% +$261 ﹤0.01% 384
2025
Q3
$20.5K Hold
140
﹤0.01% 278
2025
Q2
$21.8K Hold
140
﹤0.01% 271
2025
Q1
$23.1K Hold
140
﹤0.01% 278
2024
Q4
$22.8K Hold
140
﹤0.01% 275
2024
Q3
$27.4K Hold
140
﹤0.01% 242
2024
Q2
$24.3K Hold
140
﹤0.01% 236
2024
Q1
$23.7K Hold
140
﹤0.01% 234
2023
Q4
$27.6K Hold
140
﹤0.01% 216
2023
Q3
$24.4K Hold
140
﹤0.01% 226
2023
Q2
$24.1K Buy
+140
New +$24.2K ﹤0.01% 225

Other funds holding ZTS

Trust Company's ZTS Position: Q2 2026 in Review

Trust Company increased its Zoetis (ZTS) stake by 91% in Q2 2026, buying an estimated $12.2K and bringing the position to 273 shares worth $19.6K. The position accounts for ﹤0.01% of the portfolio, ranked #379.

Trust Company first reported a position in ZTS in Q2 2023 and has held it in 13 quarters since. The position peaked at $27.6K in Q4 2023. 271 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Trust Company held 273 shares of Zoetis worth $19.6K as of Q2 2026.
  • Trust Company bought 130 Zoetis shares in Q2 2026, an estimated $12.2K.
  • Zoetis made up ﹤0.01% of Trust Company's portfolio in Q2 2026, its #379 holding.
  • Trust Company first reported a position in Zoetis in Q2 2023 and has held it in 13 quarters since.
  • Trust Company's Zoetis position peaked at $27.6K in Q4 2023.
  • 271 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.